FindTrial
Sign In

Clopidogrel 75 mg daily

DRUG3 trials

Sponsors

Ottawa Heart Institute Research Corporation, Shahid Beheshti University of Medical Sciences, Guy's and St Thomas' NHS Foundation Trust

Conditions

AtherosclerosisComplication of Cardiac DefibrillatorDisorder of Cardiac Pacemaker SystemPeripheral Arterial DiseaseSilent AtherosclerosisVenous Occlusion

Phase 2

Trial of Clopidogrel After Surgery for Coronary Artery Disease (CASCADE Trial)
CompletedNCT00228423
Ottawa Heart Institute Research CorporationAtherosclerosis
Start: 2006-05-31End: 2009-07-31Updated: 2021-04-27

Unknown Phase

Prevention of Venous Obstruction After Implantation of Cardiac Pacemaker and Defibrillator
NCT02331511
Shahid Beheshti University of Medical SciencesComplication of Cardiac Defibrillator, Disorder of Cardiac Pacemaker System, Venous Occlusion
Start: 2015-10-31End: 2016-06-30Target: 100Updated: 2015-10-29
Mechanistic Study of Anti-Platelet Therapy in Atherosclerosis
Not yet recruitingNCT07169513
Guy's and St Thomas' NHS Foundation TrustPeripheral Arterial Disease, Silent Atherosclerosis
Start: 2025-10-01End: 2026-07-01Target: 60Updated: 2025-09-11

Related Papers

Eight-year follow-up of the Clopidogrel After Surgery for Coronary Artery Disease (CASCADE) trial.
2017-06-2420 citations
Impact of Clopidogrel Plus Aspirin Versus Aspirin Alone on the Progression of Native Coronary Artery Disease After Bypass Surgery
Circulation2014-09-0825 citations
Correlates of Saphenous Vein Graft Hyperplasia and Occlusion 1 Year After Coronary Artery Bypass Grafting
Circulation2013-09-1061 citations
Thrombelastographic haemostatic status and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): assessing and monitoring the antithrombotic effect of clopidogrel and aspirin versus aspirin alone in hypercoagulable patients: study protocol for a randomized controlled trial.
2012-04-279 citations